Jagdamba Biopharma Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 07-07-2024
- Paid Up Capital ₹ 0.64 M
as on 07-07-2024
- Company Age 12 Year, 2 Months
- Last Filing with ROC 31 Mar 2019
- Open Charges ₹ 2.50 M
as on 07-07-2024
- Revenue 11.97%
(FY 2019)
- Profit 32.47%
(FY 2019)
- Ebitda -37.64%
(FY 2019)
- Net Worth 5.35%
(FY 2019)
- Total Assets 9.80%
(FY 2019)
About Jagdamba Biopharma
The Company is engaged in the Trading Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2019. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.64 M.
The company currently has active open charges totaling ₹2.50 M.
Munesh Devi and Ravindra Kumar serve as directors at the Company.
- CIN/LLPIN
U74120UP2012PTC053320
- Company No.
053320
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
26 Oct 2012
- Date of AGM
30 Sep 2019
- Date of Balance Sheet
31 Mar 2019
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Company Details
- Location
Meerut, Uttar Pradesh, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Jagdamba Biopharma?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Munesh Devi  | Director | 26-Oct-2012 | Current |
| Ravindra Kumar | Director | 26-Oct-2012 | Current |
Financial Performance of Jagdamba Biopharma.
Jagdamba Biopharma Private Limited, for the financial year ended 2019, experienced significant growth in revenue, with a 11.97% increase. The company also saw a substantial improvement in profitability, with a 32.47% increase in profit. The company's net worth moved up by a moderate rise of 5.35%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Jagdamba Biopharma?
In 2016, Jagdamba Biopharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Starvision Infratech Private LimitedActive 14 years 1 monthMunesh Devi and Ravindra Kumar are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Allahabad Bank Creation Date: 24 Dec 2012 | ₹2.50 M | Open |
How Many Employees Work at Jagdamba Biopharma?
Unlock and access historical data on people associated with Jagdamba Biopharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Jagdamba Biopharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Jagdamba Biopharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
